Seeking Alpha
 

XOMA Ltd. (XOMA)

- NASDAQ
  • Clinically Sound Investor | Send Message 24 Mar

    XOMA Is Still In A Waiting Game $XOMA http://seekingalpha.com/a/1st6w
    Reply
      • LaboMedic | Send Message 13 Mar

        $XOMA Wedbush Reiterates Outperform on XOMA Corp Following 4Q:14 Update http://bit.ly/1x1ohJX
        Reply
          • Mike Zaman | Send Message 8 Mar

            Biotech Effectiveness: Horizon Pharma (HZNP), Zafgen (ZFGN), XOMA Corp (XOMA) $HZNP, $ZFGN, $XOMA http://seekingalpha.com/p/29kl4
            Reply
              • The Desert Fox | Send Message 6 Mar

                $XOMA interested to see the PhI data, but what I´m really keen on is to see finally the PhIII data ...
                Reply (6)
              • View all 6 replies
                • hatvani | Send Message 9 Mar
                  : Only visit once a year unfortunately so out of reality. On the other note, Monday should be good for $XOMA after the weekend news.
                • hatvani | Send Message 9 Mar
                  : I have no time for trading so I invest for longer term. Down a bit on this, but the potential is there.
                  • Roy Pope | Send Message 24 Feb

                    Tuesday Watchlist: $GCA $EGO $JCP $RPTP $LYG $SKYW $XOMA $PTX $RJET $JBLU
                    Reply (3)
                  • View all 3 replies
                    • Roy Pope | Send Message 24 Feb
                      : Glad I only watched. A few up and the rest down. Nice gains and horrible losses. Need to hone my formula a bit. LOL
                    • Roy Pope | Send Message 25 Feb
                      : Actually, this list is doing much better today, except for $RJET. Gonna tweak it and test it again for a 2-day hold.
                      • WItrader18 | Send Message 19 Feb

                        Both $XOMA and $SGEN look like they are breaking out. Plan to re-enter on the first pull back
                        Reply (1)
                        • The Desert Fox | Send Message 20 Feb
                          : it will rise strongly or fall deep soon.I'm quite excited to see whats coming! I'm holding on for a while now for a big gamble ;-)
                          • WItrader18 | Send Message 3 Feb

                            Back in $XOMA $3.39
                            Reply (10)
                          • View all 10 replies
                            • The Desert Fox | Send Message 18 Feb
                              : It was a bit to early to exit, but lost confidence at 3.51.Afterwards everybody is smarter. Economy is so green, it will pop easily higher
                            • The Desert Fox | Send Message 18 Feb
                              : Thinking about CTIC and CANF..Maybe worth a gamble..
                              • WItrader18 | Send Message 30 Jan

                                Waiting for $XOMA to drop below $3.50 again...again
                                Reply
                                  • WItrader18 | Send Message 26 Jan

                                    Sold $XOMA at $3.60 from $3.45
                                    Reply (5)
                                  • View all 5 replies
                                    • Le_Kabyle | Send Message 26 Jan
                                      : I prefer MACALLAN ;-)
                                    • The Desert Fox | Send Message 26 Jan
                                      : Fair enough ;-)
                                      • The Desert Fox | Send Message 22 Jan

                                        Any thoughts on when Phase 3 data for gevokizumab $XOMA is expected?
                                        Reply
                                          Visit Seeking Alpha's
                                          XOMA vs. ETF Alternatives
                                          Company Description
                                          XOMA Corpdiscovers and develops antibody-based therapeutics. Several of its antibodies have properties due to their interaction at allosteric sites on specific protein rather than the orthosteric, or active sites.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States